Clinical Trials Directory

Trials / Completed

CompletedNCT06388655

The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent

The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent Participants: a Randomized Sham-control Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Daegu Catholic University Medical Center · Academic / Other
Sex
All
Age
8 Years – 15 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to ascertain the therapeutic impact of mobile neurofeedback (MNF) in neurotypical children when compared to sham MNF. Clinical assessments were conducted both before and after the MNF intervention, and the effectiveness of the intervention was to be validated through these evaluations.

Detailed description

Neurotypical children aged 10-15 participated in the study. All subjects were assessed using the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version Korean Version (K-SADS-PL-K) and confirmed to have no psychiatric symptoms. The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months. All participants and their parents completed self-report scales and participants complete neurocognitive function assessments including the continuous performance test, Stroop, children's color trails test-1 and 2, and intelligence test at baseline and after the 3-month MNF program.

Conditions

Interventions

TypeNameDescription
DEVICEmobile neurofeedbackThe participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months.
DEVICEsham mobile neurofeedbackThe sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements. The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.

Timeline

Start date
2019-06-10
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2024-04-29
Last updated
2024-04-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06388655. Inclusion in this directory is not an endorsement.